1423-NRF1 Upregulation via ER Stress Inhibition

This scientific report identifies the transcription factor NRF1 as a critical defender against metabolic dysfunction-associated steatohepatitis (MASH). Researchers discovered that NRF1 levels are significantly depleted in patients and mice with liver disease, leading to a failure in clearing damaged proteins and an increase in ER stress. The study demonstrates that docosahexaenoic acid (DHA), an omega-3 fatty acid, effectively stabilizes NRF1 by preventing its degradation at the cellular membrane. By maintaining NRF1 levels, DHA promotes proteasome activity, which reduces oxidative damage and alleviates liver inflammation and scarring. These findings suggest that targeting the NRF1 pathway through nutritional or pharmacological means offers a promising therapeutic strategy for managing chronic liver conditions.References:Lin M, Zhang H, Chen S, et al. NRF1 is upregulated by docosahexaenoic acid to ameliorate MASH through the inhibition of ER stress[J]. Cell Death & Disease, 2026, 17(1): 47.前往小宇宙评论区与主播互动